Skip to content
value.today

mBio Diagnostics, Inc.

🇺🇸 Boulder, Colorado, USABiotechnologyFounded 2009
Total raised
$38 M
9 rounds on record
Latest round
$2 M
Mar 2021
First round on record
Dec 2010
Today
Private
No later event on record

Funding rounds

9 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of mBio Diagnostics, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Mar 2021$2 MNo. 9Under $2 million

mBio Diagnostics, Inc.: Raise no. 9, Mar 2021

Investors in this round

7 investors had bought by the notice of Mar 22, 2021: 7 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $4 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Christopher Myatt · Executive Officer, Director
  • Andrew Drenick · Director
  • Judith O'Brien · Director
  • Michael Chang · Director
  • Robert Silverman · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Christopher Myatt, CEO, by Tyler Hayden, Attorney-in-Fact. Source: SEC Form D, newest notice filed Mar 22, 2021. Read the notice at the SEC.

debt, optionsSEC
Feb 2021$10 MNo. 8$2 to $10 million

mBio Diagnostics, Inc.: Raise no. 8, Feb 2021

Investors in this round

1 investor had bought by the notice of Feb 2, 2021: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$10 M of $10 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Christopher Myatt · Executive Officer, Director
  • Andrew Drenick · Director
  • Judith O'Brien · Director
  • Michael Chang · Director
  • Robert Silverman · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Securities issued include a promissory note in the aggregate principal amount of $9,000,000 and a warrant to purchase $990,000 of the company's Series B Preferred Stock or next round of Preferred Stock.”

Signed by Christopher Myatt, CEO, by Tyler Hayden, Attorney-in-Fact. Source: SEC Form D, newest notice filed Feb 2, 2021. Read the notice at the SEC.

debt, optionsSEC
Jul 2020$6 MNo. 7$2 to $10 million

mBio Diagnostics, Inc.: Raise no. 7, Jul 2020

Investors in this round

16 investors had bought by the notice of Aug 3, 2020: 16 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$6 M of $11 M offered; $5 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Christopher Myatt · Executive Officer, Director
  • Andrew Drenick · Director
  • Judith O'Brien · Director
  • Michael Chang · Director
  • Robert Silverman · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Total amount sold includes the conversion of convertible promissory notes in the principal amount of $3,231,350.”

Signed by Christopher J. Myatt, CEO, by Tyler Hayden, Attorney-in-Fact. Source: SEC Form D and 1 amendment, newest notice filed Aug 3, 2020. Read the notice at the SEC.

equitySEC
Feb 2020$2 MNo. 6Under $2 million

mBio Diagnostics, Inc.: Raise no. 6, Feb 2020

Investors in this round

2 investors had bought by the notice of Mar 24, 2020: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $3 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Chris Myatt · Executive Officer, Director
  • Andrew Drenick · Director
  • Milton Chang · Director
  • Robert Silverman · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “The total offering amount includes Convertible Promissory Notes in the aggregate principal amount of $2,000,000 and Warrants representing 20% of the principal amount of the Convertible Promissory Notes.”

Signed by Christopher J. Myatt, CEO, by Tyler Hayden, Attorney-in-Fact. Source: SEC Form D and 1 amendment, newest notice filed Mar 24, 2020. Read the notice at the SEC.

debt, optionsSEC
Aug 2018$5 MNo. 5$2 to $10 million

mBio Diagnostics, Inc.: Raise no. 5, Aug 2018

Investors in this round

10 investors had bought by the notice of Aug 22, 2018: 10 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $6 M offered; $1 M still to sell
Smallest investment taken
$25,000
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Christopher J. Myatt · Executive Officer, Director · CEO
  • Michael J. Lochhead · Executive Officer · Executive VP/CTO
  • Milton J. Chang · Director
  • Robert J. Silverman · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Includes the conversion of $1,906,031.78 in convertible promissory notes.”

Signed by Christopher J. Myatt, CEO, By Tyler Hayden, Attorney-In-Fact. Source: SEC Form D, newest notice filed Aug 22, 2018. Read the notice at the SEC.

equitySEC
May 2018$1 MNo. 4Under $2 million

mBio Diagnostics, Inc.: Raise no. 4, May 2018

Investors in this round

1 investor had bought by the notice of May 21, 2018: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $2 M offered; $0 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Christopher J Myatt · Executive Officer, Director · CEO
  • Michael J Lochhead · Executive Officer · Exec VP/CTO
  • Sarah J Hatcher · Executive Officer · Corporate Secretary
  • Milton J Chang · Director
  • Robert J Silverman · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “The Company offered to purchase up to $1,500,000 Convertible Notes and Warrants representing 20% of the principal amount of the Convertible Notes.”

Signed by Christopher J. Myatt, Ceo. Source: SEC Form D, newest notice filed May 21, 2018. Read the notice at the SEC.

debt, optionsSEC
May 2015$6 MNo. 3$2 to $10 million

mBio Diagnostics, Inc.: Raise no. 3, May 2015

Investors in this round

14 investors had bought by the notice of May 21, 2015: 14 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$6 M of $6 M offered
Smallest investment taken
$10,000
What was sold
equity, securities to be acquired by exercising them, other: Series B Convertible Preferred Stock, warrants to purchase Series B Convertible Preferred Stock and the exercise thereof.
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Christopher Myatt · Executive Officer, Director · Chief Executive Officer and Director
  • Michael Lochhead · Executive Officer · EVP/CTO
  • Sarah Hatcher · Executive Officer · Corporate Secretary
  • Milton Chang · Director · Director
  • Robert Silverman · Director · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Christopher J. Myatt, Ceo. Source: SEC Form D, newest notice filed May 21, 2015. Read the notice at the SEC.

equitySEC
Aug 2012$4 MNo. 2$2 to $10 million

mBio Diagnostics, Inc.: Raise no. 2, Aug 2012

Investors in this round

9 investors had bought by the notice of Sep 5, 2012: 8 accredited, 1 not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $4 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
$1 million to $5 million
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Christopher Myatt · Executive Officer, Director
  • Milton Chang · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Christopher Myat, Ceo. Source: SEC Form D, newest notice filed Sep 5, 2012. Read the notice at the SEC.

equitySEC
Dec 2010$2 MNo. 1$2 to $10 million

mBio Diagnostics, Inc.: Raise no. 1, Dec 2010

Investors in this round

19 investors had bought by the notice of Jan 5, 2011: 19 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered
Smallest investment taken
no minimum stated
What was sold
equity, other: Series AA Preferred Stock, Warrants to purchase shares of Series AA Preferred Stock and the exercise thereof
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Christopher J. Myatt · Executive Officer, Director
  • Sarah C. Hatcher · Executive Officer
  • Milton J. Chang · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Includes conversion of indebtedness”

Signed by Christopher J. Myatt, Chief executive officer. Source: SEC Form D, newest notice filed Jan 5, 2011. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • mBio Diagnostics, Inc. chose not to state its revenue in its newest notice of a funding round (Mar 2021).

    SEC Form D · Mar 2021

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Mar 2021

That is all the official record says: mBio Diagnostics, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of mBio Diagnostics, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 9 rounds above had up to 19 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by mBio Diagnostics, Inc.
NameRoleNamed in
Christopher MyattExecutive officerMar 2021
Chris MyattExecutive officerMar 2020
Christopher J. MyattCEOAug 2018
Michael J. LochheadExecutive VP/CTOAug 2018
Christopher J MyattCEOMay 2018
Michael J LochheadExec VP/CTOMay 2018
Sarah J HatcherCorporate SecretaryMay 2018
Michael LochheadEVP/CTOMay 2015
Sarah HatcherCorporate SecretaryMay 2015
Sarah C. HatcherExecutive officerJan 2011
Andrew DrenickDirectorMar 2021
Christopher MyattDirectorMar 2021
Judith O'BrienDirectorMar 2021
Michael ChangDirectorMar 2021
Robert SilvermanDirectorMar 2021
Chris MyattDirectorMar 2020
Milton ChangDirectorMar 2020
Christopher J. MyattCEOAug 2018
Milton J. ChangDirectorAug 2018
Robert J. SilvermanDirectorAug 2018
Christopher J MyattCEOMay 2018
Milton J ChangDirectorMay 2018
Robert J SilvermanDirectorMay 2018